- CVS brings back coverage for Lilly’s obesity drug Zepbound Reuters
- Foundayo and Zepbound now covered for millions of Americans investor.lilly.com
- CVS to restore coverage of Zepbound, add Eli Lilly’s obesity pill to drug plans CNBC
- CVS Caremark will cover Lilly’s weight loss drug Zepbound again after patient backlash NBC News
- Pharmalittle: We’re reading about a hepatitis B drug, CVS returns Lilly obesity drug to formularies, and more statnews.com
Add Comment